SCHEMBL20214950

SCHEMBL20214950

CC(=O)N1CC(C)NCC1C

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.38
CHRNB2 P17787 3/20 0.36
CHRNA3 P32297 3/20 0.36
CHRNA4 P43681 3/20 0.36
CHRNB4 P30926 2/20 0.36
CHRNA7 P36544 1/20 0.34
TSHR P16473 2/20 0.33
MAPT P10636 1/20 0.33
CHRNB3 Q05901 1/20 0.33
CHRNA6 Q15825 1/20 0.33
ATM Q13315 1/20 0.33
PRKCB P05771 1/20 0.32
BIRC2 Q13490 1/20 0.32
GAA P10253 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PIM1 P11309 1/20 0.30
KHK P50053 1/20 0.30
MMP2 P08253 1/20 0.30
ANPEP P15144 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16250451 1.00 SIGMAR1 (0.38) SIGMAR1CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL14173610 1.00 SIGMAR1 (0.38) SIGMAR1CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL13993897 1.00 SIGMAR1 (0.38) SIGMAR1CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL15292087 1.00 SIGMAR1 (0.38) SIGMAR1CHRNB2CHRNA3CHRNA4CHRNB4
SCHEMBL2225916 0.83 SIGMAR1 (0.38) SIGMAR1TSHRMAPTPRKCBBIRC2
SCHEMBL2927085 0.83 SIGMAR1 (0.38) SIGMAR1TSHRMAPTPRKCBBIRC2
SCHEMBL21831491 0.83 SIGMAR1 (0.38) SIGMAR1TSHRMAPTPRKCBBIRC2
SCHEMBL21831861 0.83 SIGMAR1 (0.38) SIGMAR1TSHRMAPTPRKCBBIRC2
SCHEMBL2927087 0.83 SIGMAR1 (0.38) SIGMAR1TSHRMAPTPRKCBBIRC2
SCHEMBL6914506 0.83 SIGMAR1 (0.38) SIGMAR1TSHRMAPTPRKCBBIRC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116934-A1 KRASG12D PROTEIN HYDROLYSIS REGULATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 苏州泽璟生物制药股份有限公司 2023-06-29 WO disclosed
WO-2021062246-A1 CRF RECEPTOR ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2021-04-01 WO disclosed
US-9988382-B2 [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-A]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto NEUROCRINE BIOSCIENCES, INC. (US) 2018-06-05 US disclosed